GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
Financial Results:
Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q3FY25 of ₹949.00 Crores up from ₹805.00 Crore year on year, a rise of 17.89%.
Total Expenses for Q3FY25 of ₹677.00 Crores up from ₹604.00 Crores year on year, a rise of 12.09%.
Consolidated Net Profit of ₹230.00 Crores up 400.0% from ₹46.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.57, up 402.59% from ₹2.70 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
